Clinical Trials Logo

Paracetamol clinical trials

View clinical trials related to Paracetamol.

Filter by:
  • None
  • Page 1

NCT ID: NCT04251351 Recruiting - Acute Kidney Injury Clinical Trials

Effect of Paracetamol on Kidney Function in Severe Malaria

PROTECtS
Start date: December 13, 2021
Phase: Phase 3
Study type: Interventional

A randomised open labeled, parallel-group, controlled trial to assess the efficacy of paracetamol to reduce kidney dysfunction caused by cell-free haemoglobin-mediated oxidative damage in paediatric patients with falciparum malaria complicated by intravascular haemolysis.

NCT ID: NCT01947205 Completed - Analgesia Clinical Trials

Pain and Suction Curettage

Start date: November 2012
Phase: N/A
Study type: Interventional

Aim of the study was to investigate the analgesic efficacy of preoperative oral dexketoprofen trometamol, intravenous paracetamol, lidocaine spray and paracervical block with ultracaine on curettage procedure.

NCT ID: NCT01821872 Completed - Paracetamol Clinical Trials

Paracetamol CSF Pharmacokinetics Study

Start date: May 2011
Phase: Phase 4
Study type: Interventional

Despite its use for decades all over the world, the exact mechanism of action of paracetamol is not fully understood and essentially involves a combination of hypotheses. It is known to have an effect via the central nervous system, and of the many mechanisms proposed, one hypothesis is that it may have indirectly activate CB1 (cannabinoid) receptors, through its novel metabolite AM404. This study aims to elucidate cerebrospinal levels of paracetamol and to measure the concentration of its metabolites, including AM404 in CSF. This may, in turn, give us useful information on the mechanism of action of paracetamol.